Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NYR | Ann: Full Year Results FY2024 | 22/08/24 | 1 | 437 | |||
|
|||||||
NYR | Ann: Annual Report for year ended 30 June 2024 | 22/08/24 | 0 | 168 | |||
|
|||||||
NYR | Ann: Appendix 4G and Corporate Governance Statement | 22/08/24 | 0 | 127 | |||
|
|||||||
NYR | Ann: Preliminary final report | 22/08/24 | 0 | 177 | |||
|
|||||||
NYR | Ann: Brain Injury Program GLP Studies Further Update No 3 | 22/08/24 | 3 | 1.0K | |||
|
|||||||
NYR | Ann: Brain Injury Program GLP Studies Further Update | 19/08/24 | 35 | 9.1K | |||
|
|||||||
NYR | Ann: Investor Presentation | 16/08/24 | 3 | 881 | |||
|
|||||||
NYR | Ann: Significant Neuroprotection in NYR Preclinical Brain Injury | 09/08/24 | 194 | 70K | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |